Health / Health News

    Butantan Institute develops test for early detection of leptospirosis

    Butantan Institute has developed a pioneering test that can detect leptospirosis at its earliest stages, allowing treatment to start early, improving patients’ quality of life.



    Butantan Institute develops test for early detection of leptospirosis. Photo: Butantan


    The test uses a protein developed in the laboratory by Butantan researchers. This new technology proved to be superior to the conventional test recommended by the World Health Organization for detecting the disease, which only identifies antibodies when the infection is advanced.

    The new test is said to have been able to detect the disease in over 70 percent of patients who had obtained false negative results in the first few days of symptoms.

    Another positive aspect of the exam is that it showed 99 percent specificity, i.e. it specifically detected antibodies against leptospirosis, without showing a cross-reaction with other infectious diseases, like dengue and malaria.

    The institute’s goal now is to develop a rapid test, similar to those used to detect COVID-19 at drugstores. However, instead of nasal secretions, urine or blood could be collected.

    Leptospirosis is an infectious disease caused by bacteria called Leptospira, found in the urine of rats and other animals.

    It is transmitted to humans mainly through floods or contact with contaminated water. The World Health Organization estimates that some 500 thousand new cases occur worldwide each year. (Agência Brasil)

    JANUARY 21, 2024



    YOU MAY ALSO LIKE

    Increases in symptoms of depression are associated with a subsequent increase in bodyweight when measured one month later.
    Researchers have linked a decade-long decline in the blood lead levels of American Indian adults to long-term cardiovascular health benefits, including reduced blood pressure levels and a reduction in a marker associated with hypertrophic cardiomyopathy and heart failure.
    Experts today call for more value to be given to patients’ ‘lived experiences’ as a study of over 1,000 patients and clinicians found multiple examples of patient reports being under-valued.
    Cambridge scientists discover what causes pregnancy sickness – and a potential new treatment.
    Genome topology map of human retina development lays foundation for understanding diverse clinical phenotypes in simple and complex eye diseases.
    An international team of researchers has developed a handheld, non-invasive device that can detect biomarkers for Alzheimer's and Parkinson's disease.

    © 1991-2024 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact